- 2023.04.28Meiji Seika Pharma Submitted New Drug Application to Manufacture and Market ARCT-154 in Japan Topics
- 2023.04.13Change of President & CEO of Axcelead Drug Discovery Partners Press Release
- 2023.04.11Meiji Seika Pharma Announces that it has entered into an Alliance Agreement for Distribution and Sales of ARCT-154 with CSL Seqirus. Domestic manufacturing system will be promoted by ARCALIS’ mRNA drug manufacturing facility. Topics
- 2023.02.20Teijin and Axcelead to Establish Drug Discovery Research JV Press Release
- 2023.01.26NanoCarrier and Axcelead Signed Comprehensive Collaboration Agreement Press Release